Notizia - Recent Pharma, Healthcare and Biotech Happenings

Arbor Biotechnologies shining with new CRISPR enzyme Arbor Biotechnologies is shining with its new CRISPR enzyme and has successfully bagged USD 15.6 million in series A funding. The company has recently announced its first scientific discovery of a new enzyme, Cas13d, a CRISPR-Cas13 enzyme. It could offer advantages over other enzymes including small size facilitating the packaging into the viruses used to deliver CRISPR. Adaptimmune and GSK’s T-cells initiates responses in solid tumor patients Adaptimmune has received fractional responses in three out of the first four round cell/ myxoid liposarcoma (MRCLS) patients treated with its T cells. Early data has elevate...